SMILE vs. LASIK Using Contoura With Phorcides

Exclusion Criteria

• •Subjects with corneal abnormal findings including signs of keratoconus, keratoconus suspect, abnormal corneal topography, epithelial basement membrane disease, pellucid marginal degeneration, corneal degenerations, progressive and unstable myopia, irregular or unstable corneal mires on central keratometry images, and patients whose corneal thickness would cause anticipated treatment would violate the posterior 250 microns (μm) of corneal stroma from the corneal endothelium.
• •Subjects with active collagen vascular, connective tissue, autoimmune or immunodeficiency diseases
• •Pregnant or nursing females
• •Systemic disease likely to affect wound healing, such as uncontrolled diabetes and severe atopy
• •Any ocular disease such as advanced/uncontrolled glaucoma, severe dry eye, active eye infection or inflammation, recent herpes eye infection or problems resulting from past infection.
• •0.25 or 0.50 of manifest astigmatism in either eye
• •Taking the medication Isotretinoin (Accutane) or antimetabolites for any medical condition.